[Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki
Jean-Pierre
JP
Service d'Hépatogastroentérologie et INSERM U724, CHU de Nancy, 54500 Vandoeuvre, France. ip.bronowichi@chu-nancy.fr
Barraud
Hélène
H
Couzigou
Patrice
P
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D009154:Mutation; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors